The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of hepatic arterial infusion (HAI) therapy with floxuridine (FUDR) combined with systemic gemcitabine and oxaliplatin in patients with locally advanced intrahepatic cholangiocarcinoma (ICC).
 
Patrick Grierson
No Relationships to Disclose
 
Aabha Oza
No Relationships to Disclose
 
Maria Majella Doyle
No Relationships to Disclose
 
Kathryn Fowler
No Relationships to Disclose
 
Ryan Fields
No Relationships to Disclose
 
William G. Hawkins
No Relationships to Disclose
 
Chet Hammill
No Relationships to Disclose
 
Andrea Wang-Gillam
Consulting or Advisory Role - Merrimack; Newlink Genetics; pfizer
Research Funding - Abbvie (Inst); Aduro Biotech (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); CTI (Inst); EMD Serono (Inst); Halozyme (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); OncoMed (Inst); pfizer (Inst); Plexxikon (Inst); Precision Therapeutics (Inst); Verastem (Inst)
 
Manik A. Amin
No Relationships to Disclose
 
Katrina Pedersen
Speakers' Bureau - Clinical Care Options
 
Kian-Huat Lim
Stock and Other Ownership Interests - Merck
 
Ashley Morton
Speakers' Bureau - Guardant Health
Other Relationship - Guardant Health
 
Christine Cordova
No Relationships to Disclose
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Boehringer Ingelheim; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Sillajen; tyrogenex
 
William C. Chapman
No Relationships to Disclose